BindingDB logo
myBDB logout

null

SMILES: NC(CF)[C@H]1CC[C@@H](CC1)C(=O)N1CC[C@@H]([C@H]1C(=O)Nc1ccc2oc(cc2c1)C(O)=O)C1CCCCC1

InChI Key: InChIKey=KILCOSZSKDUQMQ-RWCURPEWSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 339895   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Coagulation factor XI


(Homo sapiens (Human))
BDBM339895
PNG
(US9758480, 50)
Show SMILES NC(CF)[C@H]1CC[C@@H](CC1)C(=O)N1CC[C@@H]([C@H]1C(=O)Nc1ccc2oc(cc2c1)C(O)=O)C1CCCCC1 |r,wU:7.10,16.18,wD:15.35,4.3,(-9.53,-11.25,;-8.19,-12.02,;-8.19,-13.56,;-9.53,-14.33,;-6.86,-11.25,;-5.53,-12.02,;-4.19,-11.25,;-4.19,-9.71,;-5.53,-8.94,;-6.86,-9.71,;-2.86,-8.94,;-1.53,-9.71,;-2.86,-7.4,;-4.11,-6.49,;-3.63,-5.03,;-2.09,-5.03,;-1.61,-6.49,;-.28,-7.26,;-.28,-8.8,;1.05,-6.49,;2.39,-7.26,;2.39,-8.8,;3.72,-9.57,;5.05,-8.8,;6.52,-9.28,;7.42,-8.03,;6.52,-6.79,;5.05,-7.26,;3.72,-6.49,;8.96,-8.03,;9.73,-6.7,;9.73,-9.37,;-1.32,-3.7,;.22,-3.7,;.99,-2.36,;.22,-1.03,;-1.32,-1.03,;-2.09,-2.36,)|
Show InChI InChI=1S/C29H38FN3O5/c30-16-23(31)18-6-8-19(9-7-18)28(35)33-13-12-22(17-4-2-1-3-5-17)26(33)27(34)32-21-10-11-24-20(14-21)15-25(38-24)29(36)37/h10-11,14-15,17-19,22-23,26H,1-9,12-13,16,31H2,(H,32,34)(H,36,37)/t18-,19-,22-,23?,26+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 84n/an/an/an/an/an/a



SUMITOMO DAINIPPON PHARMA CO., LTD.

US Patent


Assay Description
0.35 μg/mL human FXIa was allowed to react with a substrate and a test compound in a 30 mmol/L HEPES buffer solution (pH 7.4) that contained 145...


US Patent US9758480 (2017)


BindingDB Entry DOI: 10.7270/Q2D50Q33
More data for this
Ligand-Target Pair